Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday

• Conditions: Osteoporosis
• Interventions: Other: Questionnaires about compliance and persistence with bisphosphonates treatment

• Registration Number: NCT01854086
• Lead Sponsor: Meir Medical Center

Brief Summary

The purpose of the study is to provide information about the rate of response and persistence to drug therapies for osteoporosis. Another issue examined in this study refers to the preferences and concerns about future treatments in patients during "drug holiday".

Detailed Description

Not available

Study Timeline

• Status Verified: 2013-05
• Study First Submitted: 2013-05-06
• Study First Submitted QC: 2013-05-12
• Last Update Submitted: 2013-05-12
• Study First Posted: 2013-05-15
• Last Update Posted: 2013-05-15
• Study Start: 2013-09
• Primary Completion: 2014-02

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

• Postmenopausal women
• Diagnosis of osteoporosis in the medical record
• At least one prescription drug to treat osteoporosis in the last 5 years
• Insured by "Clalit" Health Services
• Hebrew-speaking capability and readiness to answer a questionnaire

Exclusion Criteria

• Premenopausal women
• No diagnosis of osteoporosis in the medical record
• No treatment for osteoporosis in the last 5 years
• Women who do not speak Hebrew or are unable to answer a questionnaire

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Postmenopausal women	Questionnaires about compliance and persistence with bisphosphonates treatment	Postmenopausal women treated with bisphosphonates

Primary Outcome Measures

Name	Time	Method
Compliance and persistence to osteoporosis drug therapy	Participants will be followed for the duration of their clinic visit, an average of 5 hours	Data collection will be done by questionnaires and from the medical record of the patient. The information collected will include: demographic information, measurements of bone density, additional information about the disease and treatment that the patient receives,prescription purchases and additional drugs the patient is taking (steroids, PPI's(Proton Pump Inhibitors) / H2 receptor antagonists and NSAIDs(Non Steroidal Anti Inflammatories)).

Trial Locations

Locations (1)

Meir medical center the clalit health care services group; 🇮🇱 Kfar Saba, Israel